Psoriatic Arthritis Resource Center

Bimekizumab Safe and Effective Treatment for Active Psoriatic Arthritis, Secukinumab, American College of Rheumatology and National Psoriasis Foundation Issue Joint PsA Guidelines

Bimekizumab Is a Safe and Effective Treatment for Active Psoriatic Arthritis

The randomized, double-blind BE ACTIVE trial compared bimekizumab versus placebo in patients with active psoriatic arthritis. According to the findings, bimekizumab was associated with...
covid-19, postoperative, cancellations, rheumatologists, voltaren, fracture, opioids, TXA, JIA, pain, disease, frailty, violence, rheumatic, acr, cbd, NSAIDs, humira, knee, TJA

Rheum Round-up: Interview with Researchers, Which Patients Have More Medical Visits?, and more

Here are the top stories recently covered by DocWire News in the Rheumatology section. In this edition, read an interview with two researchers behind...
Bimekizumab Safe and Effective Treatment for Active Psoriatic Arthritis, Secukinumab, American College of Rheumatology and National Psoriasis Foundation Issue Joint PsA Guidelines

PsA Patients Have More Medical Visits in Five Years Leading Up to Diagnosis

A new study evaluated healthcare utilization among psoriatic arthritis (PsA) patients in the years leading up to their diagnosis. The researchers concluded here that...
Bimekizumab Safe and Effective Treatment for Active Psoriatic Arthritis, Secukinumab, American College of Rheumatology and National Psoriasis Foundation Issue Joint PsA Guidelines

Five-year Efficacy of Secukinumab in PsA

Patients with psoriatic arthritis (PsA) may observe improved long-term outcomes with secukinumab treatment, according to the results of a five-year study. “Biologic therapies, such as...
vitamin D deficiency, deficiency, depression, RA Causes, Reducing Opioid Use in Back Pain, Arthritis and Mental Health, Do Men and Women Report OA Pain Differently?, and More

Rheum Round-up: RA Causes, Reducing Opioid Use in Back Pain, and More

Here are the top stories covered by DocWire News this week in the Rheumatology section. In this edition, read about the causes of osteoarthritis...
Ixekizumab vs. Adalimumab for PsA: A Drug Comparison

Ixekizumab vs. Adalimumab for PsA: A Drug Comparison

A study recently published in Annals of the Rheumatic Diseases found that ixekizumab may be superior to adalimumab in biologic-naïve psoriatic arthritis (PsA) patients...
covid-19, postoperative, cancellations, rheumatologists, voltaren, fracture, opioids, TXA, JIA, pain, disease, frailty, violence, rheumatic, acr, cbd, NSAIDs, humira, knee, TJA

Rheum Round-up: Kim Kardashian’s Lupus Scare, The Reality of Sports Injuries, And More

Here are the top stories covered by DocWire News this week in the Rheumatology section. In this edition, read about Kim Kardashian’s recent health...

Curated Journal Reading List